Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    February 23, 2016February 23, 2016

    Melanoma Researchers Use a New, Light-based Method to Prevent Tumor Growth in Mice

    News
    University of Massachusetts Medical School (UMMS) researchers developed a new technique using near-infrared light that was able to stimulate immune cells in melanoma mice models, and which could result in a more ... Read more
    February 16, 2016February 16, 2016

    Many Stage 3 Melanoma Patients Won’t Benefit from High-dose Interferon Therapy, Study Finds

    News
    Final results of the Sunbelt Melanoma Trial indicate that most patients with stage III melanoma do not benefit from high-dose interferon treatment, largely because improved diagnostic techniques are now capable of detecting small amounts of ... Read more
    February 11, 2016May 17, 2016

    For Treatment of Uveal Melanoma, FDA Grants Orphan Drug Status to Immunocore’s IMCgp100

    News
    The U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to IMCgp100 for the treatment of uveal melanoma. The FDA Office of Orphan Drug Products Development awards this designation ... Read more
    February 9, 2016February 9, 2016

    Rockland Immunochemicals Has New Melanoma Cell Lines Available for Research

    News
    Rockland Immunochemicals, Inc., announced the research availability of a new and diverse collection of more than 100 highly characterized human melanoma cell lines, made possible through a partnership between the company ... Read more
    February 4, 2016February 4, 2016

    Melanoma Rise Among Younger Women in US Associated with Indoor Tanning Use

    News
    University of Minnesota researchers have found that women under age 40 diagnosed with melanoma began indoor tanning at an earlier age and frequented the facilities more often than older women diagnosed with this malignancy. ... Read more
    February 2, 2016February 2, 2016

    Philogen Launches Phase 3 Melanoma Clinical Trial

    News
    Philogen S.p.A. of Siena, Italy, recently launched a pivotal clinical trial in patients with stage 3B/C melanoma, after promising results from its Phase 2 trial of a novel immunotherapeutic combination treatment. Patients with stage 3B/C ... Read more
    January 28, 2016January 28, 2016

    Predicting Melanoma Survival Looks Promising With Discovery of Genetic Marker

    News
    NYU Langone Medical Center has discovered two inherited genetic markers that might predict melanoma survival and are associated with overall shorter survival in these patients in the years following treatment. The ... Read more
    January 26, 2016January 26, 2016

    Metastatic Melanoma Combo Therapy Expanded to New Group of Patients

    News
    Bristol-Myers Squibb Company recently announced that the U.S. Food and Drug Administration (FDA) has approved the combination regimen of Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive unresectable ... Read more
    January 21, 2016January 21, 2016

    For Melanoma Patients, Added Benefits of Nivolumab Noted

    News
    After submitting additional information to Germany on the drug nivolumab’s side effects and clinical data for the treatment of advanced melanoma submitted by the drug manufacturer, a German drug approval agency said ... Read more
    January 19, 2016January 19, 2016

    Advanced Melanoma Combination Treatment Found Superior to Monotherapy

    News
    A study from the German Institute for Quality and Efficiency in Health Care (IQWiG) shows that combination therapy with dabrafenib and trametinib in advanced melanoma is superior to treatment with trametinib alone. Since 2013, dabrafenib ... Read more
    January 14, 2016January 14, 2016

    First Melanoma Patients Dosed in Trials of Investigational Drug PV-10

    News
    Provectus Biopharmaceuticals of Knoxville, Tenn., has confirmed the first dosage of PV-10 in two clinical trials to patients with both Stage 3 locally advanced cutaneous melanoma and Stage 4 metastatic melanoma. Both trials are ... Read more
    January 12, 2016January 12, 2016

    Skin Melanoma Heritability Among Twins is Significant, New Study Finds

    News
    The familial risk and heritability of several types of cancer in a large population of identical and fraternal twins was the subject of a recent long-term study, revealing that having a twin diagnosed ... Read more
    January 7, 2016January 7, 2016

    Skin Substitute for Rare Congenital Condition Seeks Special FDA Recognition

    News
    Amarantus BioScience Holdings, Inc., announced it has requested Rare Pediatric Disease Designation and Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) to use its Engineered Skin Substitute (ESS) as a potential treatment ... Read more
    January 5, 2016May 17, 2016

    Amgen’s IMLYGIC Approved by the European Commission To Treat Metastatic Melanoma Patients

    News
    Amgen’s IMLYGIC (talimogene laherparepvec) is the first oncolytic immunotherapy to show evidence of therapeutic benefit in patients with metastatic melanoma in a Phase III clinical trial. As a result, the ... Read more
    December 17, 2015December 17, 2015

    New Melanoma Drug Shows Promise in Resistant and Unresponsive Cancers

    News
    Sanford Burnham Prebys Medical Discovery Institute (SBP) researchers discovered a new drug, SBI-756, which inhibits melanoma cell growth in vitro, and delays disease onset and reduces the incidence of melanoma in ... Read more
    December 15, 2015December 15, 2015

    Rare Sugar L-Fucose May Help Block Tumor and Metastasis Growth

    News
    New research suggests that a rare sugar found in seaweed, mushrooms, seeds, and other foods may be helpful when treating skin cancer. The L-fucose sugar has been formerly associated with a ... Read more
    December 10, 2015December 10, 2015

    Metastatic Melanoma Immunotherapy Shows Promise in Mice Study

    News
    Memgen LLC, a company that develops cancer immunotherapies, presented positive preclinical data for its main immuno-oncology drug, ISF35, during the 30th annual meeting of the Society of Immunotherapy of Cancer (SITC), ... Read more
    December 4, 2015December 3, 2015

    Array, Pierre Fabre to Collaborate on New Melanoma Drugs

    News
    Array BioPharma Inc., based in Colorado, and Pierre Fabre of France have recently announced they will collaborate on the development and commercialization of novel oncology products for the treatment of melanoma and ovarian ... Read more
    December 3, 2015December 3, 2015

    Amgen Pressing Forward with Promising Melanoma Therapy

    News
    Amgen recently presented additional results from the company’s Phase 3 clinical trial of Imlygic (talimogene laherparepvec) as a monotherapy for the treatment of metastatic melanoma, as well as new results from its ongoing ... Read more
    November 12, 2015November 12, 2015

    Roche’s New Melanoma Drug, Cotellic, Gets FDA Approval

    News
    Roche recently announced that the U.S. Food and Drug Administration (FDA) approved Cotellic (cobimetinib) used in combination with Zelboraf (vemurafenib) for the treatment of patients with BRAF V600E or V600K mutation-positive unresectable ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.